Market cap
₹2 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
-0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
0 %
-
Industry P/E
31.39
-
EV/EBITDA
-635.7
-
Debt to Equity
-0.9
-
Book Value
₹--
-
EPS
₹-1
-
Face value
10
-
Shares outstanding
4,273,500
10 Years Aggregate
CFO
₹-2.90 Cr
EBITDA
₹-1.20 Cr
Net Profit
₹-0.86 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cresanto Global
| -- | -- | 15.7 | -- | -- | 37.7 | -- |
|
BSE Healthcare*
| 7.8 | 5.0 | 6.6 | 10.1 | 25.8 | 13.9 | 11.7 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
Cresanto Global
| 17.1 | 32.3 |
|
BSE Small Cap
| 29.0 | 47.5 |
|
BSE Healthcare
| 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cresanto Global
|
4.7 | 2.0 | 0.1 | -0.4 | -540.7 | -- | -- | -0.7 |
| 2,928.9 | 36,358.8 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 34.4 | 8.0 | |
| 8,631.5 | 21,678.6 | 2,275.6 | 187.5 | 10.3 | 22.9 | 115.6 | 24.8 | |
| 2,024.5 | 15,431.1 | 2,187.2 | 649.7 | 31.5 | 19 | 24.1 | 4.3 | |
| 1,399.0 | 19,373.8 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.3 | 5.0 | |
| 2,167.4 | 34,880.6 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.2 | 8.4 | |
| 4,598.5 | 21,041.7 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.1 | 5.0 | |
| 6,056.0 | 10,034.2 | 1,408.0 | 326.9 | 30.8 | 57.1 | 30.7 | 19.1 | |
| 499.0 | 9,742.9 | 1,538.1 | 226.2 | 20.4 | 9 | 40 | 3.8 | |
| 1,111.8 | 10,223.3 | 4,858.7 | 574.1 | 14.9 | 19.7 | 18.4 | 3.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Cresanto Global
Raymed Labs Limited manufactures allopathic medicines in India. The company was incorporated in 1992 and is based in Noida, India.
-
Incorporated
1992
-
Chairman
--
-
Managing Director
Prashant Nathmal Bajaj
-
Headquarters
Gautam Budh Nagar, Uttar Pradesh
-
Website
Looking for more details about Cresanto Global Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
FAQs for Cresanto Global
What is the current share price of Cresanto Global Ltd Today?
The share price of Cresanto Global Ltd is ₹4.65 (BSE) as of 20-Apr-2026 IST. Cresanto Global Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Cresanto Global Ltd?
Since, TTM earnings of Cresanto Global Ltd is negative, P/E ratio is not available.
The P/B ratio of Cresanto Global Ltd is -0.71 times as on 20-Apr-2026, a 115 discount to its peers’ median range of 4.64 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
-0.52
|
|
2024
|
0.00
|
-0.39
|
|
2023
|
0.00
|
-0.38
|
|
2022
|
0.00
|
-0.32
|
|
2021
|
0.00
|
-0.20
|
What is the 52 Week High and Low of Cresanto Global Ltd?
The 52-week high and low of Cresanto Global Ltd are Rs 4.65 and Rs 3.32 as of 29-May-2026.
What is the market cap of Cresanto Global Ltd?
Cresanto Global Ltd has a market capitalisation of ₹ 2 Cr as on 20-Apr-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Cresanto Global Ltd?
Before investing in Cresanto Global Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.